MedTrace Logo

MED90 of Ropivacaine for Peripheral Nerve Block on Posture-evoked Pain in Spinal Anesthesia Positioning

NCT04705974 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2022-02-09

No results posted yet for this study

Summary

This study aims to determine the minimum effective dose of ropivacaine for peripheral nerve block on posture-evoked pain for spinal anesthesia in elderly patients with hip fracture. Three types of peripheral nerve block, including fascia iliaca block, femoral nerve block and Pericapsular nerve group block (PENG block) will be assessed.

Conditions

  • Hip Fractures

Interventions

PROCEDURE

Fascia iliaca block

Fascia iliaca block will be performed under ultrasound guidenance.

PROCEDURE

Femoral nerve block

Femoral nerve block will be performed under ultrasound guidenance.

PROCEDURE

Pericapsular nerve group block (PENG block)

Pericapsular nerve group block (PENG block) will be performed under ultrasound guidenance.

Sponsors & Collaborators

  • Huazhong University of Science and Technology

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
65 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-25
Primary Completion
2024-05-01
Completion
2024-05-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04705974 on ClinicalTrials.gov